NASDAQ:SNDX | Free Cash Flow | Syndax Pharmaceuticals Inc

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2014-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$50.35M
2025-12-31-$69.49M
2025-03-31-$95.16M
2024-12-31-$57.39M
2024-03-31-$83.55M
2023-12-31-$41.35M
2023-03-31-$39.23M
2022-12-31-$22.89M
2022-03-31-$41.93M
2021-12-31$100.71M
2021-03-31-$22.59M
2020-12-31-$15.63M
2020-03-31-$15.93M
2019-12-31-$12.73M
2019-03-31-$16.83M
2018-12-31-$15.04M$14,000.00-$15.06M
2018-03-31-$19.87M$173,000.00-$20.04M
2017-12-31-$12.72M$42,000.00-$12.76M
2017-03-31-$12.67M
2016-12-31-$10.42M$0.00-$10.42M
2016-03-31-$6.4M$133,000.00-$6.54M
2015-12-31-$4.3M$31,000.00-$4.33M
2015-03-31$11.05M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$322.98M$187,000.00-$323.17M
2024-12-31-$274.9M$0.00-$274.9M
2023-12-31-$160.6M$0.00-$160.6M
2022-12-31-$133.68M$0.00-$133.68M
2021-12-31$29.13M$129,000.00$29M116.35%
2020-12-31-$71.26M$0.00-$71.26M
2019-12-31-$50.61M
2018-12-31-$68.53M$187,000.00-$68.72M
2017-12-31-$47.37M$84,000.00-$47.46M
2016-12-31-$35.16M$261,000.00-$35.42M
2015-12-31-$2.43M$49,000.00-$2.48M
2014-12-31-$14.39M$4,000.00-$14.4M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.